Table 2.
0–16 h | Adult Male (%) | Male Mean Survival (days) |
Control | 75.9 ± 3.5 | 22.4 ± 2.9 |
20 Gy | 48.1 ± 2.9 * | 19.0 ± 2.1 |
30 Gy | 12.2 ± 1.8 * | 18.9 ± 2.2 |
40 Gy | 2.0 ± 1.0 * | 17.4 ± 2.0 * |
50 Gy | 0.3 ± 0.3 * | 15.6 ± 1.9 * |
a 60 Gy | 0.0 ± 0.0 * | 14.7 ± 1.7 * |
16–24 h | Adult Male (%) | Male Mean Survival (days) |
Control | 76.0 ± 3.7 | 23.2 ± 3.2 |
20 Gy | 50.8 ± 3.0 * | 20.2 ± 2.4 |
30 Gy | 22.0 ± 2.3 * | 19.2 ± 2.3 |
40 Gy | 0.9 ± 1.1 * | 18.8 ± 2.3 * |
50 Gy | 0.3 ± 0.2 * | 15.9 ± 2.1 * |
a 60 Gy | 0.0 ± 0.0 * | 15.0 ± 2.0 * |
24–36 h | Adult Male (%) | Male Mean Survival (days) |
Control | 75.8 ± 3.2 | 24.5 ± 3.3 |
20 Gy | 48.1 ± 2.7 * | 23.7 ± 3.2 |
30 Gy | 17.9 ± 2.0 * | 21.3 ± 3.1 |
40 Gy | 0.5 ± 0.4 * | 20.3 ± 3.1 * |
50 Gy | 0.2 ± 0.1 * | 17.4 ± 2.4 * |
a 60 Gy | 0.0 ± 0.0 * | 15.6 ± 2.1 * |
36–48 h | Adult Male (%) | Male Mean Survival (days) |
Control | 74.8 ± 3.0 | 22.84 ± 3.1 |
20 Gy | 41.0 ± 2.3 * | 22.68 ± 3.1 |
30 Gy | 9.9 ± 1.6 * | 19.5 ± 3.0 |
40 Gy | 0.3 ± 0.2 * | 17.8 ± 2.7 * |
50 Gy | 0.2 ± 0.1 * | 14.1 ± 2.1 * |
a 60 Gy | 0.0 ± 0.0 * | 13.4 ± 1.8 * |
* Means (±SD) in rows and columns were statistically significant the level of p > 0.001. a Adult male in the dose of 60 Gy is as the (P) generation.